Stockholm - Free Realtime Quote SEK

Enorama Pharma AB (publ) (ERMA.ST)

Compare
3.3200 -0.1700 (-4.87%)
As of 3:27:56 PM GMT+1. Market Open.
Loading Chart for ERMA.ST
DELL
  • Previous Close 3.4900
  • Open 3.4700
  • Bid 3.3200 x --
  • Ask 3.6500 x --
  • Day's Range 3.3200 - 3.6900
  • 52 Week Range 2.0000 - 10.5000
  • Volume 11,795
  • Avg. Volume 11,737
  • Market Cap (intraday) 200.771M
  • Beta (5Y Monthly) 1.48
  • PE Ratio (TTM) --
  • EPS (TTM) -3.1600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Enorama Pharma AB (publ), a pharmaceutical company, produces and supplies medical chewing gum and other nicotine products. It also offers nicotine pouches and medical cannabis products. Enorama Pharma AB (publ) was incorporated in 2006 and is based in Malmö, Sweden.

www.enorama.se

5

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ERMA.ST

View More

Performance Overview: ERMA.ST

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ERMA.ST
1.19%
OMX Stockholm 30 Index
2.00%

1-Year Return

ERMA.ST
23.68%
OMX Stockholm 30 Index
8.02%

3-Year Return

ERMA.ST
85.57%
OMX Stockholm 30 Index
5.49%

5-Year Return

ERMA.ST
91.70%
OMX Stockholm 30 Index
40.97%

Compare To: ERMA.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ERMA.ST

View More

Valuation Measures

Annual
As of 1/9/2025
  • Market Cap

    211.05M

  • Enterprise Value

    201.77M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.87

  • Price/Book (mrq)

    6.26

  • Enterprise Value/Revenue

    15.17

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -59.86%

  • Return on Equity (ttm)

    -160.87%

  • Revenue (ttm)

    5.87M

  • Net Income Avi to Common (ttm)

    -41.41M

  • Diluted EPS (ttm)

    -3.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.38M

  • Total Debt/Equity (mrq)

    0.95%

  • Levered Free Cash Flow (ttm)

    -29.68M

Research Analysis: ERMA.ST

View More

Company Insights: ERMA.ST

Research Reports: ERMA.ST

View More

People Also Watch